In particular, BDNF has been the subject of significant basic and clinical research with regards to ELA/MDD, as it has been the subject of candidate gene studies, and shows promise as a biomarker and target for epigenome targeted antidepressant therapy. The gene discussed is BDNF; the disease is major depressive disorder.